Want the latest research?
USA: +1 (212) 201-1308
Pharmaceuticals Market Research
-
United Arab Emirates Pharmaceuticals and Healthcare Report Q4 2011
Date of report : Oct 21, 2011$530.00BMI View: In 2010, the UAE pharmaceutical market reached a value of AED5.10bn (US$1.39bn). One of the key drivers of growth for the UAE pharmaceutical market is increased health expenditure. BMI expects that most of the value development will be realised in the prescription sector, boosted by rising... Learn More -
Venezuela Pharmaceuticals and Healthcare Report Q2 2011
Date of report : Aug 4, 2011$530.00BMI View: President Hugo Chavez's distortive economic policies are increasingly damaging Venezuela's attractiveness to pharmaceutical firms. The government's latest measure, which extended price controls to medicines not previously subject to the regulations, will cause a significant reduction in re... Learn More -
Iraq Pharmaceuticals and Healthcare Report Q2 2011
Date of report : Aug 4, 2011$530.00BMI View: Iraq is viewed as a challenging pharmaceuticals and healthcare market, despite the significant population size, of over 30mn. While regulatory improvements and the theoretically sound intellectual property (IP) regime do make for an interesting commercial proposition, the security situatio... Learn More -
Australia Agribusiness Report Q2 2011
Date of report : Aug 4, 2011$530.00BMI View: We expect Australian agriculture to see growth across the board in 2010/11 on the back of better yields and overall fair weather. Given consumption's already high base, we do not expect to see significant changes. We foresee further consolidation in the agriculture sector, such as in the s... Learn More -
Lithuania Pharmaceuticals and Healthcare Report Q2 2011
Date of report : Aug 4, 2011$530.00BMI View: We continue to view Lithuania as one of the less attractive Central and Eastern European (CEE) pharmaceutical markets. Despite the favourable risks profile offered by Lithuania and its Baltic peers, the reasoning behind this view hinges on a slow economic recovery, persistently high unempl... Learn More -
India Pharmaceuticals and Healthcare Report Q2 2011
Date of report : Aug 4, 2011$530.00BMI View: India's pharmaceutical market beguiles multinational pharmaceutical companies. Sales of medicines are booming and red tape will prevent systematic price cuts, which is a nascent trend in developing countries. A rapidly increasing prevalence of non-communicable diseases, such as hypertensio... Learn More -
Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
Date of report : Jul 6, 2011$3,500.00Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure Summary GBI Research, leading business intelligence provider, has released its latest research report, ‘Top R&D Drug Failures - Toxicity and Serious Adverse Events in L... Learn More -
ENT Devices Market to 2017 - Cochlear Implants and Bone Anchored Hearing Implants are the Fastest Growing Segments
Date of report : Jul 6, 2011$3,500.00ENT Devices Market to 2017 - Cochlear Implants and Bone Anchored Hearing Implants are the Fastest Growing Segments Summary GBI Research’s report, ‘ENT Devices Market to 2017 - Cochlear Implants and Bone Anchored Hearing Implants are the Fastest Growing Segments’ provides key data, informatio... Learn More -
Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
Date of report : Jul 6, 2011$3,500.00Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development Summary GBI Research, a leading business intelligence provider, has released its latest research “Comparative Analysis of Late Stage Pipeli... Learn More -
Peripheral Ulcerative Keratitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Date of report : Jul 1, 2011$2,000.00Peripheral Ulcerative Keratitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Peripheral Ulcerative Keratitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an... Learn More
My Cart
You have no items in your shopping cart.
Compare Reports
You have no items to compare.
Loading...